PHARMACEUTICAL FORMULATION FOR INTRAVENOUS OR INTRAMUSCULAR OCTREOTIDE ADMINISTRATION

A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterised in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JODAS FARRES, GEMMA, BACARDIT CABADO, JORDI, PONSATI OBIOLS, BERTA, CLEMENTE RODRIGUEZ, FRANCISCO JAVIER, PAVON FERNANDEZ, SERGI
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JODAS FARRES, GEMMA
BACARDIT CABADO, JORDI
PONSATI OBIOLS, BERTA
CLEMENTE RODRIGUEZ, FRANCISCO JAVIER
PAVON FERNANDEZ, SERGI
description A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterised in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of hydrochloric acid in sufficient quantity to adjust the pH of the formulation to values between 3.0 and 4.2.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1153615B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1153615B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1153615B13</originalsourceid><addsrcrecordid>eNrjZAgN8HAM8nV0dg0N8XR29FFw8w_yDfVxDPH09wOxFTz9QoIcw1z9_EODFWBc39BgZ6CaIAV_55AgV_8QTxdXBUcXX08_z2CgLEgrDwNrWmJOcSovlOZmUHBzDXH20E0tyI9PLS5ITE7NSy2Jdw0wNDQ1NjM0dTI0JkIJAHXkMO0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL FORMULATION FOR INTRAVENOUS OR INTRAMUSCULAR OCTREOTIDE ADMINISTRATION</title><source>esp@cenet</source><creator>JODAS FARRES, GEMMA ; BACARDIT CABADO, JORDI ; PONSATI OBIOLS, BERTA ; CLEMENTE RODRIGUEZ, FRANCISCO JAVIER ; PAVON FERNANDEZ, SERGI</creator><creatorcontrib>JODAS FARRES, GEMMA ; BACARDIT CABADO, JORDI ; PONSATI OBIOLS, BERTA ; CLEMENTE RODRIGUEZ, FRANCISCO JAVIER ; PAVON FERNANDEZ, SERGI</creatorcontrib><description>A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterised in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of hydrochloric acid in sufficient quantity to adjust the pH of the formulation to values between 3.0 and 4.2.</description><edition>7</edition><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030226&amp;DB=EPODOC&amp;CC=EP&amp;NR=1153615B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030226&amp;DB=EPODOC&amp;CC=EP&amp;NR=1153615B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JODAS FARRES, GEMMA</creatorcontrib><creatorcontrib>BACARDIT CABADO, JORDI</creatorcontrib><creatorcontrib>PONSATI OBIOLS, BERTA</creatorcontrib><creatorcontrib>CLEMENTE RODRIGUEZ, FRANCISCO JAVIER</creatorcontrib><creatorcontrib>PAVON FERNANDEZ, SERGI</creatorcontrib><title>PHARMACEUTICAL FORMULATION FOR INTRAVENOUS OR INTRAMUSCULAR OCTREOTIDE ADMINISTRATION</title><description>A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterised in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of hydrochloric acid in sufficient quantity to adjust the pH of the formulation to values between 3.0 and 4.2.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAgN8HAM8nV0dg0N8XR29FFw8w_yDfVxDPH09wOxFTz9QoIcw1z9_EODFWBc39BgZ6CaIAV_55AgV_8QTxdXBUcXX08_z2CgLEgrDwNrWmJOcSovlOZmUHBzDXH20E0tyI9PLS5ITE7NSy2Jdw0wNDQ1NjM0dTI0JkIJAHXkMO0</recordid><startdate>20030226</startdate><enddate>20030226</enddate><creator>JODAS FARRES, GEMMA</creator><creator>BACARDIT CABADO, JORDI</creator><creator>PONSATI OBIOLS, BERTA</creator><creator>CLEMENTE RODRIGUEZ, FRANCISCO JAVIER</creator><creator>PAVON FERNANDEZ, SERGI</creator><scope>EVB</scope></search><sort><creationdate>20030226</creationdate><title>PHARMACEUTICAL FORMULATION FOR INTRAVENOUS OR INTRAMUSCULAR OCTREOTIDE ADMINISTRATION</title><author>JODAS FARRES, GEMMA ; BACARDIT CABADO, JORDI ; PONSATI OBIOLS, BERTA ; CLEMENTE RODRIGUEZ, FRANCISCO JAVIER ; PAVON FERNANDEZ, SERGI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1153615B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2003</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JODAS FARRES, GEMMA</creatorcontrib><creatorcontrib>BACARDIT CABADO, JORDI</creatorcontrib><creatorcontrib>PONSATI OBIOLS, BERTA</creatorcontrib><creatorcontrib>CLEMENTE RODRIGUEZ, FRANCISCO JAVIER</creatorcontrib><creatorcontrib>PAVON FERNANDEZ, SERGI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JODAS FARRES, GEMMA</au><au>BACARDIT CABADO, JORDI</au><au>PONSATI OBIOLS, BERTA</au><au>CLEMENTE RODRIGUEZ, FRANCISCO JAVIER</au><au>PAVON FERNANDEZ, SERGI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL FORMULATION FOR INTRAVENOUS OR INTRAMUSCULAR OCTREOTIDE ADMINISTRATION</title><date>2003-02-26</date><risdate>2003</risdate><abstract>A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterised in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of hydrochloric acid in sufficient quantity to adjust the pH of the formulation to values between 3.0 and 4.2.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP1153615B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICAL FORMULATION FOR INTRAVENOUS OR INTRAMUSCULAR OCTREOTIDE ADMINISTRATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A44%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JODAS%20FARRES,%20GEMMA&rft.date=2003-02-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1153615B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true